REVIEW ARTICLE |
|
Year : 2014 | Volume
: 5
| Issue : 4 | Page : 123-132 |
|
Management of myelodysplastic syndromes: Expert consensus opinion from the Saudi MDS Working Group
Ahmed Alaskar1, Abdul Kareem Al Momen2, Ahmad Al-Saeed1, Ahmed Al Sagheir3, Amr Hanbali4, Ayman Al-Hejazi1, Hani Al-Hashmi3, Khalid Al-Anazi3, Mohsen Al Zahrani1, Saud Abu Harbesh4, Zayed Al-Zahrani1
1 King Abdullah International Medical Research Center; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia 2 King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia 3 King Fahad Specialist Hospital, Dammam, Saudi Arabia 4 Security Forces Hospital, Riyadh, Saudi Arabia
Correspondence Address:
Dr. Ahmed Alaskar Division of Adult Hematology and SCT, King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, POB 22490, Riyadh 11426 Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1658-5127.146946
|
|
Myelodysplastic syndromes (MDSs) constitute a heterogeneous group of clonal hematopoietic disorders. A panel of Saudi hematologists representing the Saudi MDS Working Group convened with two international experts to develop the guidelines for MDS diagnosis and treatment. The recommendations were formulated on the basis of a list of real cases and therapy-related questions. The diagnostic procedures should help distinguish MDS from other causes of cytopenia and dysplasia and other clonal stem cell disorders. Blood smear, bone marrow aspirate and biopsy, and cytogenetic testing are among the mandatory diagnostic tests in MDS. Higher resolution genetic testing like mutational analysis and single nucleotide polymorphisms can be suggested for the workup depending on the clinical condition and availability of these technologies. The Working Group stressed that the heterogeneity of MDS strongly withstands a risk-adapted treatment strategy based on the international prognostic scoring system risk group of patients. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|